Questioning the limits of Moore’s law

Bringing Chemistry to Life

Content provided by Thermo Fisher Scientific. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Thermo Fisher Scientific or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3y ago 30:11

MP3•Episode home

Visit https://thermofisher.com/bctl to register for your free Bringing Chemistry to Life T-shirt and https://www.alfa.com/en/chemistry-podcasts/ to access our episode summary sheet, which contains links to recent publications and additional content recommendations for our guest.

The unstoppable progress in computational power that we have experienced in the last few decades, and that has changed the world as we know it, is almost entirely due to the relentless efforts of cramming an increasing number of transistors in microprocessors. Moore’s law, predicting a linear increase in microchip transistor density, doubling every two years, has been consistently proven right, but we are now approaching physical limitations as resolution breaking the 5 nm barrier is quickly approaching molecular dimensions. This is why many think Moore’s law is dead and this is why Rudy Wojtecki and the conventions-challenging teams at IBM Almaden Research Center are working on developing new paradigms for the computers of the future.

Rudy is a polymer chemist by background and a true multidisciplinary scientist at heart. His work on self-assembling polymers and surface chemistry is innovating the way microchips are manufactured, and the way research is done at Almaden is providing a brilliant example of different scientific disciplines working together to accelerate progress.

We read every email so please share your questions and feedback with us!

Email helloBCTL@thermofisher.com

About Your Host

Born and raised in Italy, Paolo Braiuca, a PhD in pharmaceutical sciences, co-founded a startup company after conducting research in biocatalysis in Italy and the UK. He transitioned from R&D to business development, working in commercial, product management, and marketing roles in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK. A busy father of four, if asked, he’ll call himself a “maker” at heart and enjoys inventing electronic devices in his free time.

51 episodes